| The multifaceted circulating endothelial cell in cancer: towards marker and target identification F Bertolini, Y Shaked, P Mancuso, RS Kerbel Nature Reviews Cancer 6 (11), 835-845, 2006 | 731 | 2006 |
| Maximum tolerable dose and low-dose metronomic chemotherapy have opposite effects on the mobilization and viability of circulating endothelial progenitor cells F Bertolini, S Paul, P Mancuso, S Monestiroli, A Gobbi, Y Shaked, ... Cancer research 63 (15), 4342-4346, 2003 | 624 | 2003 |
| Resting and activated endothelial cells are increased in the peripheral blood of cancer patients P Mancuso, A Burlini, G Pruneri, A Goldhirsch, G Martinelli, F Bertolini Blood, The Journal of the American Society of Hematology 97 (11), 3658-3661, 2001 | 562 | 2001 |
| Vaccination of metastatic melanoma patients with autologous tumor-derived heat shock protein gp96-peptide complexes: clinical and immunologic findings F Belli, A Testori, L Rivoltini, M Maio, G Andreola, MR Sertoli, G Gallino, ... Journal of Clinical Oncology 20 (20), 4169-4180, 2002 | 543 | 2002 |
| Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: implications for antiangiogenic drugs as chemosensitizing agents Y Shaked, E Henke, JML Roodhart, P Mancuso, MHG Langenberg, ... Cancer cell 14 (3), 263-273, 2008 | 533 | 2008 |
| Circulating endothelial cells AD Blann, A Woywodt, F Bertolini, TM Bull, JP Buyon, RM Clancy, ... Thrombosis and haemostasis 93 (02), 228-235, 2005 | 497 | 2005 |
| Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis: implications for cellular surrogate marker analysis of antiangiogenesis Y Shaked, F Bertolini, S Man, MS Rogers, D Cervi, T Foutz, K Rawn, ... Cancer cell 7 (1), 101-111, 2005 | 465 | 2005 |
| Angiogenesis in myelodysplastic syndromes G Pruneri, F Bertolini, D Soligo, N Carboni, A Cortelezzi, PF Ferrucci, ... British journal of cancer 81 (8), 1398-1401, 1999 | 374 | 1999 |
| Metronomic cyclophosphamide and capecitabine combined with bevacizumab in advanced breast cancer S Dellapasqua, F Bertolini, V Bagnardi, E Campagnoli, E Scarano, ... Journal of clinical oncology 26 (30), 4899-4905, 2008 | 346 | 2008 |
| Optimal biologic dose of metronomic chemotherapy regimens is associated with maximum antiangiogenic activity Y Shaked, U Emmenegger, S Man, D Cervi, F Bertolini, Y Ben-David, ... Blood 106 (9), 3058-3061, 2005 | 324 | 2005 |
| Antagonism of peripheral inflammation reduces the severity of status epilepticus N Marchi, Q Fan, C Ghosh, V Fazio, F Bertolini, G Betto, A Batra, E Carlton, ... Neurobiology of disease 33 (2), 171-181, 2009 | 316 | 2009 |
| Circulating endothelial-cell kinetics and viability predict survival in breast cancer patients receiving metronomic chemotherapy P Mancuso, M Colleoni, A Calleri, L Orlando, P Maisonneuve, G Pruneri, ... Blood 108 (2), 452-459, 2006 | 303 | 2006 |
| CXCR4 neutralization, a novel therapeutic approach for non-Hodgkin’s lymphoma F Bertolini, C Dell’Agnola, P Mancuso, C Rabascio, A Burlini, ... Cancer research 62 (11), 3106-3112, 2002 | 302 | 2002 |
| Drug repurposing in oncology—patient and health systems opportunities F Bertolini, VP Sukhatme, G Bouche Nature reviews Clinical oncology 12 (12), 732-742, 2015 | 294 | 2015 |
| Locoregional recurrence risk after lipofilling in breast cancer patients JY Petit, E Botteri, V Lohsiriwat, M Rietjens, F De Lorenzi, C Garusi, ... Annals of Oncology 23 (3), 582-588, 2012 | 291 | 2012 |
| Sorafenib in patients with advanced biliary tract carcinoma: a phase II trial C Bengala, F Bertolini, N Malavasi, C Boni, E Aitini, C Dealis, S Zironi, ... British journal of cancer 102 (1), 68-72, 2010 | 274 | 2010 |
| Incidence and clinicopathologic features of gastrointestinal stromal tumors. A population-based study C Mucciarini, G Rossi, F Bertolini, R Valli, C Cirilli, I Rashid, L Marcheselli, ... BMC cancer 7, 1-7, 2007 | 273 | 2007 |
| Evaluation of fat grafting safety in patients with intra epithelial neoplasia: a matched-cohort study JY Petit, M Rietjens, E Botteri, N Rotmensz, F Bertolini, G Curigliano, ... Annals of oncology 24 (6), 1479-1484, 2013 | 235 | 2013 |
| Megakaryocytic progenitors can be generated ex vivo and safely administered to autologous peripheral blood progenitor cell transplant recipients F Bertolini, M Battaglia, P Pedrazzoli, G Antonio Da Prada, A Lanza, ... Blood, The Journal of the American Society of Hematology 89 (8), 2679-2688, 1997 | 234 | 1997 |
| In vitro assessment of the quality of stored platelet concentrates S Murphy, P Rebulla, F Bertolini, S Holme, G Moroff, E Snyder, ... Transfusion medicine reviews 8 (1), 29-36, 1994 | 234 | 1994 |
